Know Cancer

or
forgot password

Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity. (KWF RUG 2004-3157)


N/A
N/A
N/A
Open (Enrolling)
Male
Non-Seminomatous Testicular Cancer

Thank you

Trial Information

Cardiovascular Morbidity in Testicular Cancer Survivors: Study of Risk Factors and Assessment of Pharmacogenomic Determinants of Toxicity. (KWF RUG 2004-3157)


Inclusion Criteria:



- Patients with non-seminomatous testicular cancer

- Have been uniformly treated with orchidectomy and cisplatin-bleomycin combination
chemotherapy at the University Hospital Groningen, The Netherlands, since 1977 but
before 01-01-2000 are eligible.

Exclusion Criteria:

- N/A

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Principal Investigator

Elisabeth G.E. de Vries, MD, PhD

Investigator Role:

Study Director

Investigator Affiliation:

University Medical Centre Groningen

Authority:

Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Study ID:

KWF RUG 2004-3157

NCT ID:

NCT00161174

Start Date:

July 2005

Completion Date:

December 2010

Related Keywords:

  • Non-Seminomatous Testicular Cancer
  • testicular cancer
  • cardiovascular morbidity
  • cardiovascular risk factors
  • pharmacogenomic determinants
  • Testicular Neoplasms

Name

Location